These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 27559923)
1. SYGNALing a Red Light for Glioblastoma. Brooks AN; Mueller WF; Steinmetz LM Cell Syst; 2016 Aug; 3(2):118-120. PubMed ID: 27559923 [TBL] [Abstract][Full Text] [Related]
2. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme. Heiland DH; Gaebelein A; Börries M; Wörner J; Pompe N; Franco P; Heynckes S; Bartholomae M; hAilín DÓ; Carro MS; Prinz M; Weber S; Mader I; Delev D; Schnell O Mol Cancer Res; 2018 Apr; 16(4):655-668. PubMed ID: 29330292 [TBL] [Abstract][Full Text] [Related]
3. Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis. Plaisier CL; O'Brien S; Bernard B; Reynolds S; Simon Z; Toledo CM; Ding Y; Reiss DJ; Paddison PJ; Baliga NS Cell Syst; 2016 Aug; 3(2):172-186. PubMed ID: 27426982 [TBL] [Abstract][Full Text] [Related]
4. Integrated regulatory models for inference of subtype-specific susceptibilities in glioblastoma. Liu Y; Shi N; Regev A; He S; Hemann MT Mol Syst Biol; 2020 Sep; 16(9):e9506. PubMed ID: 32974985 [TBL] [Abstract][Full Text] [Related]
5. Metformin treatment reduces temozolomide resistance of glioblastoma cells. Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206 [TBL] [Abstract][Full Text] [Related]
6. A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity. Riddick G; Kotliarova S; Rodriguez V; Kim HS; Linkous A; Storaska AJ; Ahn S; Walling J; Belova G; Fine HA Sci Rep; 2017 Mar; 7():43605. PubMed ID: 28256619 [TBL] [Abstract][Full Text] [Related]
9. Analyzing Differential Regulatory Networks Modulated by Continuous-State Genomic Features in Glioblastoma Multiforme. Chiu YC; Hsiao TH; Wang LJ; Chen Y; Chuang EY IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1754-1764. PubMed ID: 28114032 [TBL] [Abstract][Full Text] [Related]
10. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis. Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852 [TBL] [Abstract][Full Text] [Related]
11. Using evolutional properties of gene networks in understanding survival prognosis of glioblastoma. Upton A; Arvanitis TN IEEE J Biomed Health Inform; 2014 May; 18(3):810-6. PubMed ID: 24058043 [TBL] [Abstract][Full Text] [Related]
12. Drug and disease signature integration identifies synergistic combinations in glioblastoma. Stathias V; Jermakowicz AM; Maloof ME; Forlin M; Walters W; Suter RK; Durante MA; Williams SL; Harbour JW; Volmar CH; Lyons NJ; Wahlestedt C; Graham RM; Ivan ME; Komotar RJ; Sarkaria JN; Subramanian A; Golub TR; Schürer SC; Ayad NG Nat Commun; 2018 Dec; 9(1):5315. PubMed ID: 30552330 [TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells. Zeng H; Xu N; Liu Y; Liu B; Yang Z; Fu Z; Lian C; Guo H Int J Oncol; 2017 Aug; 51(2):445-455. PubMed ID: 28714520 [TBL] [Abstract][Full Text] [Related]
16. Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma. Gupta MK; Jayaram S; Reddy DN; Polisetty RV; Sirdeshmukh R J Proteome Res; 2015 Dec; 14(12):5017-27. PubMed ID: 26464075 [TBL] [Abstract][Full Text] [Related]
17. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers. Chiu YC; Hsiao TH; Chen Y; Chuang EY BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma. Li Y; Wang Z; Wang Y; Zhao Z; Zhang J; Lu J; Xu J; Li X Oncotarget; 2016 Jul; 7(29):45027-45041. PubMed ID: 26943771 [TBL] [Abstract][Full Text] [Related]
19. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma. Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940 [TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV. Narsia N; Ramagiri P; Ehrmann J; Kolar Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]